Richwood Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-485
Closed -$264K 105
2025
Q4
$264K Sell
485
-115
-19% -$65K 0.19% 94
2025
Q3
$291K Sell
600
-107
-15% -$49.8K 0.23% 84
2025
Q2
$287K Hold
707
0.24% 84
2025
Q1
$352K Sell
707
-36
-5% -$19.5K 0.3% 76
2024
Q4
$387K Hold
743
0.32% 73
2024
Q3
$460K Buy
743
+13
+2% +$7.7K 0.38% 68
2024
Q2
$404K Hold
730
0.35% 69
2024
Q1
$424K Sell
730
-10
-1% -$5.61K 0.38% 67
2023
Q4
$393K Hold
740
0.37% 69
2023
Q3
$375K Hold
740
0.38% 71
2023
Q2
$386K Hold
740
0.38% 70
2023
Q1
$427K Hold
740
0.43% 65
2022
Q4
$408K Hold
740
0.41% 70
2022
Q3
$375K Sell
740
-55
-7% -$30.8K 0.41% 70
2022
Q2
$432K Hold
795
0.44% 68
2022
Q1
$470K Hold
795
0.42% 68
2021
Q4
$530K Buy
+795
New +$496K 0.46% 54

Other funds holding TMO

Richwood Investment Advisors's TMO Position: Q1 2026 in Review

Richwood Investment Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 485 shares — an estimated $264K sold.

Richwood Investment Advisors first reported a position in TMO in Q4 2021 and held it in 17 quarters. The position peaked at $530K in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Richwood Investment Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Richwood Investment Advisors sold 485 Thermo Fisher Scientific shares in Q1 2026, an estimated $264K.
  • Richwood Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 17 quarters.
  • Richwood Investment Advisors's Thermo Fisher Scientific position peaked at $530K in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Richwood Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.